Considering the well-established oncogenic role of Trop2 in various cancers including breast cancer, our studies suggest that Trop2 may potentially lead to an oncogene-mediated metabolic reprogramming in TNBC by regulating a group of metabolic genes and oncogenes. This evidence concerns the gene TACSTD2 and breast carcinoma.